A Novel Peptide Derived from Arca inflata Induces Apoptosis in Colorectal Cancer Cells through Mitochondria and the p38 MAPK Pathway

Colorectal carcinoma (CRC) is one of the major causes of cancer-related incidence and deaths. Here, we identified a novel antitumor peptide, P6, with a molecular weight of 2794.8 Da from a marine Chinese medicine, Reeve. The full amino acid sequence and secondary structure of P6 were determined by t...

Full description

Saved in:
Bibliographic Details
Published inMarine drugs Vol. 20; no. 2; p. 110
Main Authors Li, Chunlei, Zhang, Sirui, Zhu, Jianhua, Huang, Weijuan, Luo, Yuanyuan, Shi, Hui, Yu, Dongbo, Chen, Liguo, Song, Liyan, Yu, Rongmin
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 29.01.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Colorectal carcinoma (CRC) is one of the major causes of cancer-related incidence and deaths. Here, we identified a novel antitumor peptide, P6, with a molecular weight of 2794.8 Da from a marine Chinese medicine, Reeve. The full amino acid sequence and secondary structure of P6 were determined by tandem mass de novo sequencing and circular dichroism spectroscopy, respectively. P6 markedly inhibited cell proliferation and colony formation, and induced apoptosis in CRC cells. Mechanistically, transcriptomics analysis and a serial functional evaluation showed that P6 induced colon cancer cell apoptosis through the activation of the p38-MAPK signaling pathway. Moreover, it was demonstrated that P6 exhibited antitumor effects in a tumor xenograft model, and induced cell cycle arrest in CRC cells in a concentration-dependent mode. These findings provide the first line of indication that P6 could be a potential therapeutic agent for CRC treatment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:1660-3397
1660-3397
DOI:10.3390/md20020110